A randomized phase II study of pemetrexed versus pemetrexed plus carboplatin in chemotherapy-naive elderly patients with IIIB/IV non-squamous non-small cell lung cancer.
Phase 2
Recruiting
- Conditions
- chemotherapy-naive elderly patients with IIIB/IV non-squamous non-small cell lung cancer
- Registration Number
- JPRN-UMIN000006129
- Lead Sponsor
- Division of Medical Oncology and Molecular Respirology, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1)Squamous cell carcinoma 2)Radiation therapy to primary cancer 3)SVC syndrome 4)Severe drug allergy 5)Massive or uncontrollable pleural effusion 6)Massive ascites, or pericardial effusion 7)Recurrence of postoperative NSCLC patients 8)Active infectious diseases 9)Interstitial pneumonia recognized by chest X-ray 10)CNS metastases with symptoms 11)Active multiple cancers 12)Psychological disorders 13)Inappropriate patients for this study judged by the physicians
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method